| 标题 |
Efficacy and safety of the dual SGLT1 and SGLT2 inhibitor JP-2266 in Type 2 Diabetes: a randomized, double-blind, placebo-controlled, phase 2 study (Diabetes Metab J, published online July 29, 2026) |
| 网址 | |
| DOI | |
| 其它 |
期刊:Diabetes & Metabolism 作者:Chan Zhang 出版日期:2026-11-07 |
| 求助人 | |
| 下载 | 该求助完结已超 24 小时,文件已从服务器自动删除,无法下载。 |
PDF的下载单位、IP信息已删除
(2025-6-4)